Global pioneers of convenient treatment for allergy and immune related disorders.
Transforming lives by delivering convience.
As a Healthcare professional, you understand the importance of convenience in allergy treatments, because this allows you to deliver the best patient care.
We are a visionary immunology business with specialist experience in the research and development of allergy treatments.
Work with us.
Does targeted micronutrition with the holoBLG lozenge induce long-term effects in house dust mite allergic patients?
TARGET – Long-term benefit of allergen-specific immunotherapy with MCT-associated pollen SCIT allergoids on asthma in children and adolescents under real life conditions
Ara h 2-expressing virus-like particle (VLP) induces IL-10-producing B regulatory cells in peanut-allergic individuals: Novel therapeutic candidate for peanut allergy.
Modulation of Th2, Th2A, T follicular helper cells and induction of Th1 cells by Ara h 2-expressing virus-like particles (VLP): A novel therapeutic vaccine candidate for peanut allergy
Induction of type 1 dendritic cell-associated genes by Ara h 2-expressing virus-like particle (VLP): A novel immune modulatory approach for peanut allergy
